TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 1 | 6 | 7 | -3 | 29 | 27 | 0 | 13 |
| P | %wins | 100 | 100 | 0 | 100 | 100 | 80 | ||||
| S | %ret | 1 | 1 | 1 | -4 | -1 | -30 | 0 | 0 | 0 | -12 |
| S | %wins | 100 | 100 | 100 | 100 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7/28/17 19:00 | 7/28/17 | ARLZ | Aralez Pharmaceuticals Inc. | A1 | Health | Drug | Pharmaceutical Preparations | Charles Scott J | A6 | O | CFO | S | -14 | 1.25 | 0 | -11 | -4 | 281 | D | ||||||||||||||
3/22/17 16:18 | 3/20/17 | ARLZ | Aralez Pharmaceuticals Inc. | A1 | Health | Drug | Pharmaceutical Preparations | Charles Scott J | A6 | O | CFO | S | -13 | 2.41 | 5 | -5 | -2 | 208 | D | -70 | -43 | -59 | -54 | -45 | -44 | -36 | 3 | -4 | -1 | -30 | |||
5/16/16 20:33 | 5/12/16 | ARLZ | Aralez Pharmaceuticals Inc. | A1 | Health | Drug | Pharmaceutical Preparations | Charles Scott J | A6 | O | CFO | P | 174 | 3.49 | 2 | 50 | 31 | 213 | D | -59 | -47 | -47 | -38 | -12 | -17 | -7 | 0 | 6 | 7 | -3 | 29 | 27 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |